Print page      E-mail page

Investor Relations The investor pages that follow are your resource for financial information about Poniard Pharmaceuticals. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information. Recent Releases Jun 5, 2009 Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference May 28, 2009 Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer more » Events Jun 10, 2009 8th Annual Needham Life Sciences Conference May 31, 2009 Poniard Pharmaceuticals Investor Briefing more »

Stock Information PARD - (NASDAQ) $6.68   + 0.02 Jul 2, 2009 4:11 PM ET  Shareholder Tools Investor Briefcase Investor Kit News & Event Alerts Download Library Investor FAQs News Feeds Investor site Section only Quotes delayed at least 20 minutes. Information provided by eSignal.